Oncology & Cancer
HIV drug shows efficacy in treating mouse models of HER2+ breast cancer
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the ...
Oct 6, 2012
0
0